Stage 3 leukemia almost always refers to Rai stage III chronic lymphocytic leukemia (CLL). It means a person with CLL has developed anemia, with hemoglobin below 11 g/dL, because leukemia cells are crowding the bone marrow. It is considered high-risk disease and usually means treatment should start, but many people at this stage respond well to modern therapy.
Patients are often surprised to learn that most leukemias are not staged the way breast or colon cancers are. Leukemia already lives in the blood and marrow, so “spread” is not the question. Instead, doctors look at how much the disease is affecting normal blood production. This article explains what stage 3 means, how it is diagnosed, and what treatment looks like.
Why Most Leukemias Do Not Have a “Stage 3”
Leukemia is a cancer of blood-forming cells that starts in the bone marrow. Because it circulates from the start, the familiar TNM staging used for solid tumors does not apply. Each leukemia type is classified in its own way:
- Chronic lymphocytic leukemia (CLL): staged with the Rai system (stages 0 to IV) or the Binet system (stages A to C).
- Chronic myeloid leukemia (CML): described by phase: chronic, accelerated or blast phase.
- Acute myeloid and acute lymphoblastic leukemia (AML and ALL): not staged. Doctors use subtype, genetic findings and response to treatment to judge risk.
So when a report or a relative mentions “stage 3 leukemia,” it nearly always means Rai stage III CLL. If you are unsure which system applies to you, ask your hematologist directly. Leukemia is one of several hematologic disorders where the name of the disease matters more than a number.
The Rai Staging System Explained
The Rai system builds step by step. Each stage adds a new finding to the ones before it. Stage 3 is the point where CLL starts to interfere with red cell production.
| Rai stage | Defining findings | Risk group |
|---|---|---|
| 0 | Lymphocytosis only (high lymphocyte count in blood and marrow) | Low |
| I | Lymphocytosis plus enlarged lymph nodes | Intermediate |
| II | Lymphocytosis plus enlarged spleen or liver | Intermediate |
| III | Lymphocytosis plus anemia (hemoglobin below 11 g/dL) | High |
| IV | Lymphocytosis plus low platelets (below 100,000/µL) | High |
Enlarged lymph nodes, spleen or liver may be present at stage 3, but they are not required. The defining feature is anemia. For comparison, a healthy adult hemoglobin is roughly 12.0 to 15.5 g/dL in women and 13.5 to 17.5 g/dL in men.
An Important Detail About Anemia
The anemia must come from the leukemia filling the marrow. CLL can also cause autoimmune hemolytic anemia, where the immune system destroys red cells. That type of anemia is treated differently and does not, on its own, place someone in stage 3. It is also why doctors look for other causes, such as iron deficiency or bleeding, before assigning a stage.
The Binet Equivalent
Europe more commonly uses the Binet system. Binet stage C, defined by hemoglobin below 10 g/dL or platelets below 100,000/µL, broadly overlaps with Rai stages III and IV. If you see Binet C on a report, the practical meaning is similar.
Symptoms of Stage 3 Leukemia
Many people with early CLL have no symptoms at all. By stage 3, the anemia usually produces noticeable effects because the body has fewer red blood cells to carry oxygen:
- Fatigue and reduced exercise tolerance
- Shortness of breath on exertion
- Pale skin, lips or nail beds
- Dizziness or a racing heartbeat
- Painless swelling of lymph nodes in the neck, armpits or groin
- Fullness under the left ribs from an enlarged spleen
Some people also develop “B symptoms”: fevers without infection, drenching night sweats and unintentional weight loss. Frequent infections are common in CLL because the immune system does not work normally.
How Stage 3 Leukemia Is Diagnosed
Diagnosis and staging of CLL rely mostly on blood tests and a physical examination.
- Complete blood count (CBC): shows a raised lymphocyte count and, at stage 3, a hemoglobin below 11 g/dL.
- Peripheral blood smear: shows small mature-looking lymphocytes and characteristic “smudge cells.”
- Flow cytometry: confirms CLL by identifying the pattern of surface markers on the cells. A count of at least 5,000 clonal B cells per µL is needed for the diagnosis.
- Genetic tests: FISH testing for deletion 17p and other changes, TP53 mutation testing and IGHV mutation status. These strongly guide treatment choice.
- Anemia work-up: reticulocyte count, direct antiglobulin (Coombs) test and iron studies to rule out other causes.
A bone marrow biopsy is not always needed for CLL, but it can help when the cause of anemia is unclear. Imaging is used selectively.
Treatment for Stage 3 Leukemia
Early-stage CLL is often watched without treatment. Stage 3 is different: anemia from marrow involvement is a recognized reason to begin therapy. Treatment has changed a great deal in recent years, with targeted drugs largely replacing traditional chemotherapy for most patients.
- BTK inhibitors such as ibrutinib, acalabrutinib and zanubrutinib, taken as daily tablets, usually on a continuous basis.
- Venetoclax, a BCL-2 inhibitor, commonly combined with the antibody obinutuzumab for a fixed course of about one year.
- Chemoimmunotherapy, now used less often, mainly for selected younger patients with favorable genetics.
- Supportive care: transfusions if needed, vaccinations, and prompt treatment of infections.
Allogeneic stem cell transplantation is reserved for a small number of people whose disease stops responding to other treatments. CAR T-cell therapy has also become an option for some people with relapsed CLL. If other types of leukemia are affecting your blood counts, the approach differs completely, which is why an exact diagnosis matters.
Outlook for Stage 3 Leukemia
Stage 3 is classed as high-risk CLL, and historically survival was shorter than in earlier stages. Staging is only one piece of the picture, though. Genetic markers such as TP53 status and IGHV mutation, age, and overall health often predict outcome as strongly as stage does.
With modern targeted therapies, many people with stage 3 CLL see their blood counts recover and live for many years. Your hematologist can give you a personalized estimate. For comparison with earlier disease, see our guide to stage 2 leukemia survival.
Frequently Asked Questions
Is stage 3 leukemia curable?
CLL is generally considered treatable rather than curable with standard therapy. However, many people achieve deep, long-lasting remissions and live with it as a chronic condition for years.
Does stage 3 mean the leukemia has spread?
No. Leukemia is in the blood and marrow from the beginning. Stage 3 means the leukemia is now affecting red blood cell production enough to cause anemia.
Can anemia cause leukemia?
No, it works the other way around: leukemia can cause anemia. Anemia has many common, harmless causes, which we explain in our article on whether anemia can cause leukemia.
Can someone move back to an earlier stage after treatment?
The original stage stays in the record, but treatment can bring blood counts back to normal. Doctors then describe the response, such as complete or partial remission, rather than restaging.
When to See a Doctor
If you have CLL, contact your care team promptly about new fatigue, breathlessness, fevers, night sweats, weight loss or frequent infections. These can signal that anemia is developing or the disease is progressing. Seek urgent care for fever with chills, chest pain or severe breathlessness. For a broader overview of leukemia types, visit our leukemia guide.
